These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8494383)

  • 1. 2-substituted quinoline alkaloids as potential antileishmanial drugs.
    Fournet A; Barrios AA; Muñoz V; Hocquemiller R; Cavé A; Bruneton J
    Antimicrob Agents Chemother; 1993 Apr; 37(4):859-63. PubMed ID: 8494383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo efficacy of oral and intralesional administration of 2-substituted quinolines in experimental treatment of new world cutaneous leishmaniasis caused by Leishmania amazonensis.
    Fournet A; Ferreira ME; Rojas De Arias A; Torres De Ortiz S; Fuentes S; Nakayama H; Schinini A; Hocquemiller R
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2447-51. PubMed ID: 8913444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activity of 2-substituted quinoline alkaloids in BALB/c mice infected with Leishmania donovani.
    Fournet A; Gantier JC; Gautheret A; Leysalles L; Munos MH; Mayrargue J; Moskowitz H; Cavé A; Hocquemiller R
    J Antimicrob Chemother; 1994 Mar; 33(3):537-44. PubMed ID: 8040117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of orally administered 2-substituted quinolines in experimental murine cutaneous and visceral leishmaniases.
    Nakayama H; Loiseau PM; Bories C; Torres de Ortiz S; Schinini A; Serna E; Rojas de Arias A; Fakhfakh MA; Franck X; Figadère B; Hocquemiller R; Fournet A
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4950-6. PubMed ID: 16304157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Berberine derivatives as antileishmanial drugs.
    Vennerstrom JL; Lovelace JK; Waits VB; Hanson WL; Klayman DL
    Antimicrob Agents Chemother; 1990 May; 34(5):918-21. PubMed ID: 2360830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meglumine Antimoniate (Glucantime) Causes Oxidative Stress-Derived DNA Damage in BALB/c Mice Infected by Leishmania (Leishmania) infantum.
    Moreira VR; de Jesus LCL; Soares RP; Silva LDM; Pinto BAS; Melo MN; Paes AMA; Pereira SRF
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate.
    Barroso PA; Marco JD; Calvopina M; Kato H; Korenaga M; Hashiguchi Y
    J Antimicrob Chemother; 2007 Jun; 59(6):1123-9. PubMed ID: 17439977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of natural naphthoquinones in BALB/c mice infected with Leishmania amazonensis and L. venezuelensis.
    Fournet A; Barrios AA; Muñoz V; Hocquemiller R; Cavé A
    Trop Med Parasitol; 1992 Dec; 43(4):219-22. PubMed ID: 1293723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo anti-leishmanial activity of chlorpromazine alone and combined with N-meglumine antimonate.
    el-On J; Rubinstein N; Kernbaum S; Schnur LF
    Ann Trop Med Parasitol; 1986 Oct; 80(5):509-17. PubMed ID: 3632098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intralesional treatment of cutaneous leishmaniasis: a report of two cases].
    Clarós P; Wienberg P; González MA; Clarós A; Clavería MA; López P
    Acta Otorrinolaringol Esp; 1996; 47(1):67-70. PubMed ID: 8645493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo host and parasite response to antileishmanial drugs and immunomodulators.
    Gonzalez-Fajardo L; Fernández OL; McMahon-Pratt D; Saravia NG
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003820. PubMed ID: 26024228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral delivery of meglumine antimoniate-beta-cyclodextrin complex for treatment of leishmaniasis.
    Demicheli C; Ochoa R; da Silva JB; Falcão CA; Rossi-Bergmann B; de Melo AL; Sinisterra RD; Frézard F
    Antimicrob Agents Chemother; 2004 Jan; 48(1):100-3. PubMed ID: 14693525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responses of Leishmania (Viannia) braziliensis cutaneous infection to N-methylglucamine antimoniate in the rhesus monkey (Macaca mulatta) model.
    Teva A; Porrozzi R; Oliveira-Neto MP; Grimaldi GJ
    J Parasitol; 2005 Aug; 91(4):976-8. PubMed ID: 17089782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility to pentavalent antimony in Leishmania infantum strains is not modified during in vitro or in vivo passages but is modified after host treatment with meglumine antimoniate.
    Carrió J; Portús M
    BMC Pharmacol; 2002 May; 2():11. PubMed ID: 12019027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel organic salts based on quinoline derivatives: The in vitro activity trigger apoptosis inhibiting autophagy in Leishmania spp.
    Calixto SL; Glanzmann N; Xavier Silveira MM; da Trindade Granato J; Gorza Scopel KK; Torres de Aguiar T; DaMatta RA; Macedo GC; da Silva AD; Coimbra ES
    Chem Biol Interact; 2018 Sep; 293():141-151. PubMed ID: 30098941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antileishmanial activity of a tetralone isolated from Ampelocera edentula, a Bolivian plant used as a treatment for cutaneous leishmaniasis.
    Fournet A; Barrios AA; Muñoz V; Hocquemiller R; Roblot F; Cavé A
    Planta Med; 1994 Feb; 60(1):8-12. PubMed ID: 8134421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of residual Sb(III) in meglumine antimoniate cytotoxicity and MRP1-mediated resistance.
    Dzamitika SA; Falcão CA; de Oliveira FB; Marbeuf C; Garnier-Suillerot A; Demicheli C; Rossi-Bergmann B; Frézard F
    Chem Biol Interact; 2006 Apr; 160(3):217-24. PubMed ID: 16524568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake and antileishmanial activity of meglumine antimoniate-containing liposomes in Leishmania (Leishmania) major-infected macrophages.
    Borborema SE; Schwendener RA; Osso JA; de Andrade HF; do Nascimento N
    Int J Antimicrob Agents; 2011 Oct; 38(4):341-7. PubMed ID: 21783345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A chloroquinoline derivate presents effective in vitro and in vivo antileishmanial activity against Leishmania species that cause tegumentary and visceral leishmaniasis.
    Sousa JKT; Antinarelli LMR; Mendonça DVC; Lage DP; Tavares GSV; Dias DS; Ribeiro PAF; Ludolf F; Coelho VTS; Oliveira-da-Silva JA; Perin L; Oliveira BA; Alvarenga DF; Chávez-Fumagalli MA; Brandão GC; Nobre V; Pereira GR; Coimbra ES; Coelho EAF
    Parasitol Int; 2019 Dec; 73():101966. PubMed ID: 31362122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antileishmanial activity of 1,3,4-thiadiazolium-2-aminide in mice infected with Leishmania amazonensis.
    Rodrigues RF; Charret KS; da Silva EF; Echevarria A; Amaral VF; Leon LL; Canto-Cavalheiro MM
    Antimicrob Agents Chemother; 2009 Feb; 53(2):839-42. PubMed ID: 19015338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.